← Leaderboards
Dara L Kraitchman
Johns Hopkins University
$14,405,090
Attributed
$18,292,777
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,292,777 · 13
By mechanism
R01$14,053,178 · 7
R33$2,083,232 · 1
R21$1,108,878 · 2
K02$537,489 · 1
S10$500,000 · 1
R13$10,000 · 1
Top collaborators
- Clifford Raabe Weiss7 shared
- Brian H. Ladle5 shared
- George Sgouros2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Jeff W Bulte$21,671,493
- Clifford Raabe Weiss$2,216,626
- Catherine M Gordon$5,650,865
- Mingde Lin$3,164,519
- Robert Francois Hobbs$5,138,973
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingSafetyAnimal ModelTranslationsCellsClinical TrialsIncidenceImageOperative Surgical ProceduresMalignant NeoplasmsAffectAmericanAnimalsCanis FamiliarisImage GuidedClientPreventCancer TherapyTumorClinically RelevantLabelMedicalRoentgen RaysHeart Function
Grant awards (41)
Alpha-Emitter Therapy of Osteosarcoma$666,045
R01 · FY2025 · CA · contact PI
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity$621,857
R01 · FY2025 · DK · contact PI
Exosome-mediated therapy for liver cancer$65,311
R21 · FY2025 · CA · contact PI
MR-compatible Devices for the Diagnosis and Treatment of Cardiomyopathies$764,660
R01 · FY2024 · HL · contact PI
Alpha-Emitter Therapy of Osteosarcoma$681,116
R01 · FY2024 · CA
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity$663,314
R01 · FY2024 · DK · contact PI
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$596,467
R01 · FY2024 · CA · contact PI
Exosome-mediated therapy for liver cancer$229,659
R21 · FY2024 · CA · contact PI
MR-compatible Devices for the Diagnosis and Treatment of Cardiomyopathies$766,346
R01 · FY2023 · HL · contact PI
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity$690,951
R01 · FY2023 · DK · contact PI
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$615,301
R01 · FY2023 · CA · contact PI
MR-compatible Devices for the Diagnosis and Treatment of Cardiomyopathies$766,346
R01 · FY2022 · HL · contact PI
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$615,301
R01 · FY2022 · CA · contact PI
MR-compatible Devices for the Diagnosis and Treatment of Cardiomyopathies$791,786
R01 · FY2021 · HL · contact PI
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$627,858
R01 · FY2021 · CA · contact PI
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma$637,376
R01 · FY2020 · CA · contact PI
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity$344,250
R01 · FY2016 · EB · contact PI
Scholarship and Mentorship Expansion at the 19th SCMR Scientific Sessions$10,000
R13 · FY2016 · EB · contact PI
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity$337,365
R01 · FY2015 · EB · contact PI
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity$333,923
R01 · FY2014 · EB · contact PI
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity$344,250
R01 · FY2013 · EB · contact PI
X-ray & MR-visible Microencapsulation of Allogeneic Arteriogenic Cell Therapeutic$688,884
R33 · FY2011 · HL · contact PI
X-ray & MR-visible Microencapsulation of Allogeneic Arteriogenic Cell Therapeutic$695,841
R33 · FY2010 · HL · contact PI
X-ray & MR-visible Microencapsulation of Allogeneic Arteriogenic Cell Therapeutic$698,507
R33 · FY2009 · HL · contact PI
X-ray & MR-visible Microencapsulation of Allogeneic Arteriogenic Cell Therapeutic$409,852
R21 · FY2008 · HL · contact PI
X-ray & MR-visible Microencapsulation of Allogeneic Arteriogenic Cell Therapeutic$404,056
R21 · FY2007 · HL · contact PI
Imaging Cardiac Regeneration with Mesenchymal Stem Cells$607,530
R01 · FY2006 · HL · contact PI
Imaging Cardiac Regeneration with Mesenchymal Stem Cells$43,311
R01 · FY2006 · HL · contact PI
Imaging Cardiac Regeneration with Mesenchymal Stem Cells$555,436
R01 · FY2005 · HL
Imaging Cardiac Regeneration with Mesenchymal Stem Cells$488,191
R01 · FY2004 · HL
MR IMAGING OF MYOCARDIAL VIABILITY AFTER ISCHEMIC INSULT$107,779
K02 · FY2004 · HL
Imaging Cardiac Regeneration with Mesenchymal Stem Cells$479,551
R01 · FY2003 · HL
MR IMAGING OF MYOCARDIAL VIABILITY AFTER ISCHEMIC INSULT$215,882
R01 · FY2003 · HL
MR IMAGING OF MYOCARDIAL VIABILITY AFTER ISCHEMIC INSULT$107,633
K02 · FY2003 · HL
MR IMAGING OF MYOCARDIAL VIABILITY AFTER ISCHEMIC INSULT$256,757
R01 · FY2002 · HL
MR IMAGING OF MYOCARDIAL VIABILITY AFTER ISCHEMIC INSULT$107,492
K02 · FY2002 · HL
CARDIOVASCULAR ANIMAL RESEARCH X-RAY IMAGING SYSTEM$500,000
S10 · FY2001 · RR
MR IMAGING OF MYOCARDIAL VIABILITY AFTER ISCHEMIC INSULT$257,640
R01 · FY2001 · HL
MR IMAGING OF MYOCARDIAL VIABILITY AFTER ISCHEMIC INSULT$107,357
K02 · FY2001 · HL
MR IMAGING OF MYOCARDIAL VIABILITY AFTER ISCHEMIC INSULT$284,368
R01 · FY2000 · HL
MR IMAGING OF MYOCARDIAL VIABILITY AFTER ISCHEMIC INSULT$107,228
K02 · FY2000 · HL